Skip to main content
. 2020 Jun 8;14:949–961. doi: 10.2147/PPA.S242336

Table 1.

Participant Characteristics, by Region and Overalla

US (N = 25) Europeb (N = 50) Brazil (N = 10) Total (N = 85)
Demographic characteristics
Sex, n (%)
 Female 18 (72.0) 27 (54.0) 6 (60.0) 51 (60.0)
Current age (years), mean (SD) 48.1 (12.4) 51.1 (12.9) 47.3 (10.0) 49.8 (12.5)
Education,cn (%)
 Primary school 1 (4.0) 6 (14.6) 2 (20.0) 9 (11.8)
 Secondary school 6 (24.0) 19 (46.3) 3 (30.0) 28 (36.8)
 College/university degree 18 (72.0) 16 (39.0) 5 (50.0) 39 (51.3)
 Prefer not to answer 0 (0) 9 (18.0) 0 (0) 9 (10.6)
Relationship status,cn (%)
 Single 7 (28.0) 5 (12.2) 2 (20.0) 14 (18.4)
 Cohabiting, married, or civil partnership 13 (52.0) 33 (80.5) 7 (70.0) 53 (69.7)
 Otherd 5 (20.0) 3 (7.3) 1 (10.0) 9 (11.8)
 Prefer not to answer 0 (0) 9 (18.0) 0 (0) 9 (10.6)
Race/ethnicity,cn (%)
 White 19 (76.0) 21 (100.0) 10 (100.0) 50 (89.3)
 Black 2 (8.0) 0 (0) 0 (0) 2 (3.6)
 Asian 1 (4.0) 0 (0) 0 (0) 1 (1.8)
 Hispanic 3 (12.0) 0 (0) 0 (0) 3 (5.4)
 Other 0 (0) 0 (0) 0 (0) 0 (0)
 Prefer not to answer 0 (0) 29 (58.0) 0 (0) 29 (34.1)
Healthcare coverage,cn (%)
 Private 18 (72.0) 8 (19.5) 4 (40.0) 30 (39.5)
 Medicare, Medicaid, or public assistance 7 (28.0) 32 (78.0) 6 (60.0) 45 (59.2)
 Military 0 (0) 0 (0) 0 (0) 0 (0)
 Other 0 (0) 0 (0) 0 (0) 0 (0)
 None 0 (0) 1 (2.4) 0 (0) 1 (1.3)
 Prefer not to answer 0 (0) 9 (18.0) 0 (0) 9 (10.6)
Clinical characteristics
Age (years) at PsA diagnosis, mean (SD) 37.6 (13.3) 41.1 (12.9) 37.1 (12.5) 39.6 (13.0)
PsO, NRS (0–10),e mean (SD) 4.0 (2.8) 2.7 (3.0) 5.4 (3.1) 3.4 (3.0)
Joint/ligament pain, NRS (0–10),e mean (SD) 4.7 (2.5) 4.6 (2.6) 5.6 (2.0) 4.7 (2.5)
Fatigue, NRS (0–10),e mean (SD) 5.3 (2.8) 4.9 (2.9) 6.5 (2.5) 5.2 (2.8)
Impact, NRS (0–10),e,f mean (SD) 5.7 (3.0) 5.4 (3.1) 9.1 (1.4) 5.9 (3.1)
Severity of PsA, n (%)
 Mild 9 (36.0) 15 (30.0) 1 (10.0) 25 (29.4)
 Moderate 11 (44.0) 23 (46.0) 8 (80.0) 42 (49.4)
 Severe 5 (20.0) 9 (18.0) 0 (0) 14 (16.5)
 Very severe 0 (0) 3 (6.0) 1 (10.0) 4 (4.7)
Current PsA and PsO signs and symptoms,gn (%)
 Joint pain 22 (88.0) 44 (88.0) 8 (80.0) 74 (87.1)
 Skin patches or plaques (flaking, redness) 20 (80.0) 29 (58.0) 10 (100.0) 59 (69.4)
 Stiffness 17 (68.0) 25 (50.0) 3 (30.0) 45 (52.9)
 Joint swelling 15 (60.0) 24 (48.0) 2 (20.0) 41 (48.2)
 Skin discomfort (eg itching, painful, bleeding, etc.) 15 (60.0) 17 (34.0) 5 (50.0) 37 (43.5)
 Unusual fatigue 9 (36.0) 18 (36.0) 2 (20.0) 29 (34.1)
 Joint damage 5 (20.0) 17 (34.0) 2 (20.0) 24 (28.2)
 Joint tenderness 5 (20.0) 16 (32.0) 2 (20.0) 23 (27.1)
 Swollen or inflamed (“sausage”) fingers or toes (dactylitis) 4 (16.0) 13 (26.0) 2 (20.0) 19 (22.4)
 Inflammatory back pain (back pain/stiffness) 6 (24.0) 12 (24.0) 0 (0) 18 (21.2)
 Sleep problems 5 (20.0) 10 (20.0) 1 (10.0) 16 (18.8)
 Nail changes (ie pitting or small dents, separation from nail bed) 6 (24.0) 7 (14.0) 1 (10.0) 14 (16.5)
 Tenderness or swelling of ligament/tendon that connects to the bone, commonly the heel or elbow (enthesitis) 3 (12.0) 6 (12.0) 1 (10.0) 10 (11.8)
 Eye irritation, redness, disturbed vision 1 (4.0) 5 (10.0) 0 (0) 6 (7.1)

Notes: aAll variables were patient-reported. bIncludes France, Germany, Italy, Spain, and the UK. cPercentages for responses other than “Prefer not to answer” do not include any patients who selected “Prefer not to answer”. dSeparated, divorced, or widowed. e0 indicated “none” and 10 indicated the “worst possible” of the variable. fBased on the question “How, if at all, have your PsA symptoms (including skin and musculoskeletal [joint, spine, swelling, tenderness] symptoms) impacted your life?”. gPatients could report >1 response; percentages total >100%.

Abbreviations: NRS, numerical rating scale; PsA, psoriatic arthritis; PsO, psoriasis; SD, standard deviation.